浏览全部资源
扫码关注微信
重庆大学附属肿瘤医院药学部,重庆 400030
中药师,硕士。研究方向:中药药物分析。E-mail:2433898677@qq.com
副主任药师,硕士生导师,硕士。研究方向:医院药学。E-mail:chenwanyi@cqu.edu.cn
纸质出版日期:2024-06-30,
收稿日期:2024-01-19,
修回日期:2024-04-28,
扫 描 看 全 文
李娜,汪潇潇,夏婕妤等.消核糖浆的指纹图谱及含量测定研究 Δ[J].中国药房,2024,35(12):1457-1462.
LI Na,WANG Xiaoxiao,XIA Jieyu,et al.Study on the fingerprint and content determination of Xiaohe syrup[J].ZHONGGUO YAOFANG,2024,35(12):1457-1462.
李娜,汪潇潇,夏婕妤等.消核糖浆的指纹图谱及含量测定研究 Δ[J].中国药房,2024,35(12):1457-1462. DOI: 10.6039/j.issn.1001-0408.2024.12.08.
LI Na,WANG Xiaoxiao,XIA Jieyu,et al.Study on the fingerprint and content determination of Xiaohe syrup[J].ZHONGGUO YAOFANG,2024,35(12):1457-1462. DOI: 10.6039/j.issn.1001-0408.2024.12.08.
目的
2
建立消核糖浆的高效液相色谱(HPLC)指纹图谱,并测定其中10个有效成分的含量。
方法
2
以12批消核糖浆为对象,采用超高效液相色谱-串联质谱(UPLC-MS/MS)法,以Athena C
18
(250 mm×4.6 mm,5 μm)为色谱柱,以乙腈-0.1%磷酸水溶液为流动相进行梯度洗脱,流速为1.0 mL/min,检测波长为210 nm。色谱图导入《中药色谱指纹图谱相似度评价系统(2012A版)》建立消核糖浆指纹图谱并进行相似度评价。采用ACQUITY UPLC BEH C
18
(100 mm×2.1 mm,1.7 μm)色谱柱,以0.01%甲酸乙腈-0.01%甲酸水为流动相进行梯度洗脱,流速为0.4 mL/min,结合高分辨质谱仪,以电喷雾离子源进行正负离子扫描,测定12批消核糖浆中各主要成分的含量。
结果
2
12批样品共标定33个共有峰,相似度均大于0.97;确认其中10个色谱峰,分别为王不留行黄酮苷、芍药苷、阿魏酸、柚皮苷、迷迭香酸、新橙皮苷、丹酚酸B、延胡索乙素、柴胡皂苷A、柴胡皂苷D;含量测定结果显示,上述10个成分在各自的质量浓度范围内线性关系良好(
R
2
>0.999),其含量分别为0.35~0.64、3.15~5.61、0.11~0.17、1.68~3.17、1.59~1.90、1.15~1.64、0.78~1.48、0.11~0.26、0.06~0.13、0.33~0.61 mg/mL。
结论
2
12批消核糖浆的主要成分相似但含量有所差异;本研究建立的HPLC指纹图谱和UPLC-MS/MS含量测定方法可用于消核糖浆的全面质量评价。
OBJECTIVE
2
To establish high performance liquid chromatography (HPLC) fingerprint of Xiaohe syrup and determine the contents of 10 effective ingredients in them.
METHODS
2
With 12 batches of Xiaohe syrup as samples, ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was adopted with Athena C
18
(250 mm×4.6 mm, 5 μm) as the chromatographic column, acetonitrile-0.1% phosphoric acid aqueous solution as mobile phase for gradient elution. The flow rate was 1.0 mL/min, and the detection wavelength was 210 nm.
Similarity Evaluation System for Traditional Chinese Medicine Chromatographic Fingerprint
(
2012A version
) was imported to establish the fingerprint of Xiaohe syrup and evaluate the similarity. The content determination was performed on ACQUITY UPLC BEH C
18
(100 mm×2.1 mm, 1.7 μm) chromatographic column, with 0.01% formic acid acetonitrile-0.01% formic acid water as mobile phase for gradient elution at a flow rate of 0.4 mL/min; combined with high-resolution mass spectrometer, positive and negative ions were scanned with an electric spray ion source to determine the content of each main component in 12 batches of Xiaohe syrup.
RESULTS
2
A total of 33 common peaks were calibrated in 12 batches of samples, with similarities greater than 0.97; 10 chromatographic peaks were confirmed, namely flavonoid glycosides, paeoniflorin, ferulic acid, naringin, rosmarinic acid, neohesperidin, salvianolic acid B, tetrahydropalmatine, saikosaponin A, and saikosaponin D. The results of content determination showed that the above 10 components had good linear relationships within their respective mass concentration ranges (all
R
2
>0.999), with contents ranging from 0.35 to 0.64, 3.15 to 5.61, 0.11 to 0.17, 1.68 to 3.17, 1.59 to 1.90, 1.15 to 1.64, 0.78 to 1.48, 0.11 to 0.26, 0.06 to 0.13,
and 0.33 to 0.61 mg/mL, respectively.
CONCLUSIONS
2
The main components of 12 batches of Xiaohe syrup are similar, but the contents vary; HPLC fingerprint and UPLC-MS/MS content determination method established in this study can be used for comprehensive quality evaluation of Xiaohe syrup.
消核糖浆指纹图谱质量控制含量测定超高效液相色谱-串联质谱
fingerprintquality controlcontent determinationUPLC-MS/MS
黄蓓. 《中共中央 国务院关于促进中医药传承创新发展的意见》重点任务分工方案印发[J]. 中医药管理杂志,2019,27(24):2.
HUANG B. Opinions of the Central Committee of the Communist Party of China and the State Council on Promoting the Inheritance,Innovation and Development of Traditional Chinese Medicine issued by the key task division plan[J]. J Tradit Chin Med Manag,2019,27(24):2.
王青云. 《国家药监局关于促进中药传承创新发展的实施意见》发布[J]. 中医药管理杂志,2021,29(1):129.
WANG Q Y. The Implementation Opinions of National Medical Products Administration on Promoting the Inheritance,Innovation and Development of Traditional Chinese Medicine was released[J]. J Tradit Chin Med Manag,2021,29(1):129.
罗国安,王义明. 中药指纹图谱的分类和发展[J]. 中国新药杂志,2002,11(1):46-51.
LUO G A,WANG Y M. Classification and development of TCM fingerprint[J]. Chin New Drugs J,2002,11(1):46-51.
刘祥东,梁琼麟,罗国安,等. 液质联用技术在医药领域中的应用[J]. 药物分析杂志,2005,25(1):110-116.
LIU X D,LIANG Q L,LUO G A,et al. The application of liquid chromatography-mass spectrometry in the field of medicine[J]. Chin J Pharm Anal,2005,25(1):110-116.
武少茹,冯伟红,杨立新,等. 夏枯草种子与奇亚籽、兰香子的性状、膨胀度和化学组成比较[J]. 中国实验方剂学杂志,2023,29(2):18-26.
WU S R,FENG W H,YANG L X,et al. Comparison of character,turgidity and chemical composition of Prunellae Spica seeds,Chia seeds and Basil seeds[J]. Chin J Exp Tradit Med Formulae,2023,29(2):18-26.
李春霞,余洁,陆远富,等. 丹参酮类心脑血管保护作用与机制的研究进展[J]. 中国新药与临床杂志,2016,35(8):542-546.
LI C X,YU J,LU Y F,et al. Advances in protective ef-fects of tanshinones on cardiovascular and cerebrovascu- lar diseases[J]. Chin J N Drugs Clin Remedies,2016,35(8):542-546.
张庆莲,皮凤娟,黄娟,等. 三棱-莪术药对在乳腺增生症中的应用进展[J]. 中医研究,2023,36(4):93-96.
ZHANG Q L,PI F J,HUANG J,et al. Application pro-gress of Sparganii Rhizoma-Curcumae Rhizoma in mammary hyperplasia[J]. Tradit Chin Med Res,2023,36(4):93-96.
江宝瑞,丁宏,王跃,等. 枳壳的药理研究进展[J]. 云南中医中药杂志,2022,43(6):70-75.
JIANG B R,DING H,WANG Y,et al. Pharmacological research progress of Fructus Aurantii[J]. Yunnan J Tradit Chin Med Mater Med,2022,43(6):70-75.
金玉青,洪远林,李建蕊,等. 川芎的化学成分及药理作用研究进展[J]. 中药与临床,2013,4(3):44-48.
JIN Y Q,HONG Y L,LI J R,et al. Advancements in the Chemical constituents and pharmacological effects of Chuan-xiong[J]. Pharm Clin Chin Mater Med,2013,4(3):44-48.
王丹,马晓宁,李艳娟,等. 养生中药路路通的研究进展[J]. 中国疗养医学,2017,26(3):246-248.
WANG D,MA X N,LI Y J,et al. Research progress of health preserving traditional Chinese medicine of Lulutong[J]. Chin J Conval Med,2017,26(3):246-248.
金杰,肖湘. 王不留行的化学成分、药理作用及临床应用研究进展[J]. 中国药物经济学,2022,17(4):124-128.
JIN J,XIAO X. Research progress on chemical constituents,pharmacological effects and clinical application of Semen vaccariae[J]. China J Pharm Econ,2022,17(4):124-128.
高小荣,田庚元. 白芍化学成分研究进展[J]. 中国新药杂志,2006,15(6):416-418.
GAO X R,TIAN G Y. Active principles of Paeonia lactiflora Pall[J]. Chin J N Drugs,2006,15(6):416-418.
闫雪孟,刘世勇,林诚诚,等. 白芍作用机制探究及质量标志物预测[J]. 中医药信息,2023,40(2):45-52,60.
YAN X M,LIU S Y,LIN C C,et al. Action mechanism of Paeonia Radix alba and its Q-marker prediction[J]. Inf Tradit Chin Med,2023,40(2):45-52,60.
陈斯. 延胡索化学成分和药理作用研究进展[J]. 中医药信息,2021,38(7):78-82.
CHEN S. Research progress on chemical constituents and pharmacological effects of Corydalis Rhizoma[J]. Inf Tradit Chin Med,2021,38(7):78-82.
李力恒,陈丽萍,胡晓阳,等. 柴胡的化学成分及药理作用研究进展[J]. 中医药学报,2023,51(2):109-112.
LI L H,CHEN L P,HU X Y,et al. Research progress on chemical components and pharmacological effects of Bupleuri Radix[J]. Acta Chin Med Pharmacol,2023,51(2):109-112.
王蕾萌,龙旭,龚莉,等. 丹参总黄酮提取工艺的研究进展[J]. 当代化工,2023,52(7):1706-1709.
WANG L M,LONG X,GONG L,et al. Research progress in the extraction process of total flavonoids from Salvia miltiorrhiza[J]. Contemp Chem Ind,2023,52(7):1706-1709.
吴杰,冯钰,陈伟强,等. 星点设计-效应面法优化莪术油中吉马酮的提取工艺[J]. 天然产物研究与开发,2017,29(3):497-502.
WU J,FENG Y,CHEN W Q,et al. Optimization of extraction process of germacrone from zedoary turmeric oil by central composite design and response surface metho-dology[J]. Nat Prod Res Dev,2017,29(3):497-502.
王永杰. HPLC-DAD同时测定柴胡口服液中2种柴胡皂苷的含量[J]. 微量元素与健康研究,2021,38(1):57-59.
WANG Y J. Simultaneous determination of two saikosaponins in Chaihu oral solution by HPLC-DAD[J]. Stud Trace Elem Health,2021,38(1):57-59.
赵利军,魏娟,柳漫宇,等. HPLC法评价不同产地柴胡药材的质量[J]. 湖北医药学院学报,2023,42(2):127-130.
ZHAO L J,WEI J,LIU M Y,et al. Quality evaluation of Bupleuri Radix in different origins by HPLC[J]. J Hubei Univ Med,2023,42(2):127-130.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构